Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more) Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more) Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Connacher Oil & Gas Ltd CLLZF

Energy Oil & Gas Integrated
"Connacher Oil and Gas Ltd is an oil company engaged in the exploration and development, production and marketing of bitumen. Connacher holds two producing projects at Great Divide are known as Pod One and Algar."


GREY:CLLZF - Post by User

Connacher Oil & Gas Ltd > China regulators offer VIP treatment for 48 overseas drugs
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(103)
•••
Post by G1945Von Aug 10, 2018 8:53am
138 Views
Post# 28439450

China regulators offer VIP treatment for 48 overseas drugs

China regulators offer VIP treatment for 48 overseas drugsOut of 48 one seems to compare to Apabetalone. (Bear ?)

NO.45  VORAPAXAR by Merck USA :

 

Medical uses

Vorapaxar is used for persons with a history of myocardial infarction (heart attack) or persons with peripheral arterial disease. Studies have shown that this medication can reduce the rate of combined endpoint cardiovascular death, MI, stroke, and urgent coronary revascularization.[1]


I often wonder if there is a real market for a MACE reducing drug due to lack of interest for RVX by BP. 

jmo
G1945V
 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities